近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Khan KM, Nahar L, Al-Groshi A, Zavoianu AG, Evans A, Dempster NM, Wansi JD, Ismail FMD, Mannan A, Sarker SD. 2016. Cytotoxicity of the Roots of Trillium govanianum Against Breast (MCF7), Liver (HepG2), Lung (A549) and Urinary Bladder (EJ138) Carcinoma Cells PHYTOTHERAPY RESEARCH, 30 :1716-1720 >DOI >Link Sharma S, Evans A, Hemers E. 2016. Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1. Cell Tissue Res, :357-366 >DOI >Link Bloch KM, Evans A, Lock EA. 2015. Aristolochic acids - Induced transcriptomic responses in rat renal proximal tubule cells in vitro. Genomics data, 5 :254-256 Bloch KM, Yaqoob N, Sharma S, Evans A, Aschauer L, Radford R, Jennings P, Ryan MP, Van Delft JHM, Lock EA. 2015. Transcriptomic alterations induced by Monuron in rat and human renal proximal tubule cells in vitro and comparison to rat renal-cortex in vivo TOXICOLOGY RESEARCH, 4 :423-431 >DOI >Link Pujol-Gimenez J, de Heredia FP, Angel Idoate M, Airley R, Pilar Lostao M, Evans AR. 2015. Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report JOURNAL OF CANCER, 6 :139-143 >DOI >Link Yaqoob N, Evans A, Foster JR, Lock EA. 2014. Trichloroethylene and trichloroethanol-induced formic aciduria and renal injury in male F-344 rats following 12 weeks exposure TOXICOLOGY, 323 :70-77 >DOI >Link Airley RE, McHugh P, Evans AR, Harris B, Winchester L, Buffa FM, Al-Tameemi W, Leek R, Harris AL. 2014. Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression. Br J Cancer, 110 :715-723 >DOI >Link Tawfeek HM, Evans AR, Iftikhar A, Mohammed AR, Shabir A, Somavarapu S, Hutcheon GA, Saleem IY. 2013. Dry powder inhalation of macromolecules using novel PEG-co-polyester microparticle carriers INTERNATIONAL JOURNAL OF PHARMACEUTICS, 441 :611-619 >DOI >Link Yaqoob N, Evans AR, Lock EA. 2013. Trichloroethylene-induced formic aciduria: effect of dose, sex and strain of rat. Toxicology, Evans AR, Airley R. 2012. How the science of personalized medicines will change the clinical management of patients in the pharmacy Future Medicinal Chemistry, 4 :2023-2026 Bloch KM, Yaqoob N, Evans A, Radford R, Jennings P, Boei JWA, McMorrow T, Slattery C, Ryan MP, Gmuender H, van Delft JHM, Lock EA. 2012. Detection of genotoxic and non-genotoxic renal carcinogens in vitro in NRK-52E cells using a transcriptomics approach. (2012). 1 :211-219 Airley R, Evans A, Mobasheri A, Hewitt SM. 2010. Glucose transporter Glut-1 is detectable in pen-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 192 :133-138 >DOI >Link Evans A, Bates V, Troy H, Hewitt S, Holbeck S, Chung Y-L, Phillips R, Stubbs M, Griffiths J, Airley R. 2008. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies (2008). Cancer Chemotherapy and Pharmacology, :377-393 Olidimeji B, Lerston S, Evans A, Estlin E, Airley R. 2005. Bone marrow hypoxia as a target in acute lymphoblastic leukaemia: toxicity assays using the bioreductive cytotoxic agent tirapazamine JOURNAL OF PHARMACY AND PHARMACOLOGY, 57 :S77-S77 >Link Lonergan S, Haddad N, Evans A, Airley R. 2005. Ascorbic acid toxicity in tumours: role of facilitative glucose transporter Glut-1 and hypoxia JOURNAL OF PHARMACY AND PHARMACOLOGY, 57 :S77-S77 >Link Hodgson G, Evans A, Airley R. 2005. Deregulated glucose transport as a target for anticancer drug development: use of a Glut-1 over-expressing colon carcinoma cell line to screen tyrosine kinase inhibitors for Glut-1-dependent toxicity JOURNAL OF PHARMACY AND PHARMACOLOGY, 57 :S76-S76 >Link Airley RE, Phillips RM, Evans AE, Double J, Burger AM, Feibig HH, West CML, Stratford IJ. 2005. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. Int J Oncol, 26 :1477-1484 >Link Khan KM, Nahar L, Evans A, Ismail FMD, Dempster N, Al-Groshi A, Zazoianu AG, Wansi JD, Sarker SD. Evaluation of cytotoxicity of Trillium govanianum (Melanthiaceae) Phytotherapy Research, Evans AR, Sharma S, Hemers, E . 2016. The role of High-Mobility Group Box 1 protein in mesenchymal-epithelial signalling in the tumour microenvironment. European journal of cancer, EACR 24th biennial conference 61 :S78-S78 Sheperd S, Chapman L, Day S, McHugh P, Evans AR, Airley R. 2014. The development of drug sensitivity biomarkers for personalized cancer chemotherapy Bloch KM, Evans A, van Delft J, Lock EA. 2011. The effect of four non-genotoxic carcinogens and four non-carcinogens on NRK-52E cells using a transcriptomics approach. Toxicology Research, :110-110 McAllister L, Evans A, Hutcheon G, Gaskell E. 2009. Encapsulation of epirubicin for the treatment of cancer JOURNAL OF PHARMACY AND PHARMACOLOGY, 61 :A82-A82 >Link Bloch K, Evans A, Lock EA. 2009. Developing an in vitro method for assessing the carcinogenic potential of compounds to the kidney. Toxicology, :9-9 McAllister L, Evans A, Hutcheon G, Gaskell E. 2009. Encapsulation of epirubicin for the treatment of cancer. J. Pharm. Pharmacol., Suppl. :A77-A77 Hermitage N, Evans A, Houghton P, Stratford I, Estlin E, Airley R. 2004. Hypoxia-regulated gene expression in rhabdomyosarcoma cell lines BRITISH JOURNAL OF CANCER, British Cancer Research Meeting 2004 91 :S68-S68 >Link